PARP-1 involvement in neurodegeneration: a focus on Alzheimer's and Parkinson's diseases

S Martire, L Mosca, M d'Erme - Mechanisms of ageing and development, 2015 - Elsevier
DNA damage is the prime activator of the enzyme poly (ADP-ribose) polymerase1 (PARP-1)
whose overactivation has been proven to be associated with the pathogenesis of numerous …

Nicotinamide, a poly [ADP-ribose] polymerase 1 (PARP-1) inhibitor, as an adjunctive therapy for the treatment of Alzheimer's disease

F Salech, DP Ponce, AC Paula-Lima… - Frontiers in Aging …, 2020 - frontiersin.org
Nicotinamide (vitamin B3) is a key component in the cellular production of Nicotinamide
Adenine Dinucleotide (NAD) and has long been associated with neuronal development …

Poly (ADP-ribose) polymerase-1 as a promising drug target for neurodegenerative diseases

K Thapa, H Khan, U Sharma, AK Grewal, TG Singh - Life Sciences, 2021 - Elsevier
Aims Poly (ADP-ribose) polymerase-(PARP)-1 is predominantly triggered by DNA damage.
Overexpression of PARP-1 is known for its association with the pathogenesis of several …

Parthanatos in the pathogenesis of nervous system diseases

X Wang, P Ge - Neuroscience, 2020 - Elsevier
Parthanatos is a modality of regulated cell death initiated by poly (ADP-ribose) polymerase 1
(PARP-1) hyperactivation and characterized by apoptosis inducing factor (AIF)-dependent …

[HTML][HTML] Poly (ADP-Ribose) polymerase 1 and parthanatos in neurological diseases: From pathogenesis to therapeutic opportunities

X Xu, B Sun, C Zhao - Neurobiology of Disease, 2023 - Elsevier
Abstract Poly (ADP-ribose) polymerase-1 (PARP-1) is the most extensively studied member
of the PARP superfamily, with its primary function being the facilitation of DNA damage …

Poly (ADP-ribose)(PAR)-dependent cell death in neurodegenerative diseases

H Park, TI Kam, TM Dawson, VL Dawson - International review of cell and …, 2020 - Elsevier
Disruption of cellular functions with aging-induced accumulation of neuronal stressors
causes cell death which is a common feature of neurodegenerative diseases. Studies in a …

Poly (ADP-ribose) polymerase 1 and neurodegenerative diseases: Past, present, and future

ML Hu, YR Pan, YY Yong, Y Liu, L Yu, DL Qin… - Ageing research …, 2023 - Elsevier
Abstract Poly (ADP-ribose) polymerase 1 (PARP1) is a first responder that recognizes DNA
damage and facilitates its repair. Neurodegenerative diseases, characterized by progressive …

Cell death mechanisms of neurodegeneration

J Fan, TM Dawson, VL Dawson - Neurodegenerative diseases: Pathology …, 2017 - Springer
There are common mechanisms shared by genetically or pathologically distinct
neurodegenerative diseases, such as excitotoxicity, mitochondrial deficits and oxidative …

ADP-ribosylation signalling and human disease

L Palazzo, P Mikolčević, A Mikoč, I Ahel - Open biology, 2019 - royalsocietypublishing.org
ADP-ribosylation (ADPr) is a reversible post-translational modification of proteins, which
controls major cellular and biological processes, including DNA damage repair, cell …

Nuclear poly (ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis

L McGurk, J Mojsilovic-Petrovic, VM Van Deerlin… - Acta neuropathologica …, 2018 - Springer
Amyotrophic lateral sclerosis (ALS) is a devastating and fatal motor neuron disease.
Diagnosis typically occurs in the fifth decade of life and the disease progresses rapidly …